USE OF AN EXPERIMENTAL DRUG WITH ROSIGLITAZONE SHOWN TO REDUCE SIMILAR DEGREE OF INSULIN SENSITIZATION WITHOUT THE KNOWN ADVERSE EFFECTS OF ROSIGLITAZONE

Idris, I

Idris, I (corresponding author), Univ Nottingham, Nottingham, England.

DIABETES OBESITY & METABOLISM, 2020; 22 (7): 1228